Volume 73 Number 7 November 2006	back to contents

From the Departments of ¹Emergency Medicine and ²Geriatrics, Mount Sinai Hospital, Mount Sinai School of Medicine, New York, NY.

Address all correspondence and reprint requests to Denise Nassisi, M.D., Department of Emergency Medicine, Box 1149, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029-6574; e-mail: denise.nassisi@mssm.edu.

Abstract

Delirium is an organic mental syndrome defined by a global disturbance in consciousness and cognition, which develops abruptly and often fluctuates over the course of the day. It is precipitated by medical illness, substance intoxication/withdrawal or medication effect.

Delirium is associated with significant morbidity and mortality, and is a leading presenting symptom of illness in the elderly. Elderly patients with altered mental status, including agitation, should be presumed to have delirium until proven otherwise. The clinical manifestations of delirium are highly variable. A mental status evaluation is crucial in the diagnosis of delirium.

Medical evaluation and stabilization should occur in parallel. Life-threatening etiologies including hypoxia, hypoglycemia and hypotension require immediate intervention. The differential diagnosis of etiologies of delirium is extensive. Patients with delirium need thorough evaluations to determine the underlying causes of the delirium. Pharmacological agents should be considered when agitated patient has the potential to harm themselves or others, or is impeding medical evaluation and management. Unfortunately, the evidence to guide pharmacologic management of acute agitation in the elderly is limited. Current pharmacologic options include the typical and atypical antipsychotic agents and the benzodiazepines. These therapeutic options are reviewed in detail.

Key Words

Delirium, geriatrics, agitation, antipsychotics, benzodiazepines.

MSSM Home

Back Issues | Indexes | Search | Journal Home